Tenon Medical, Inc.
For the period ended Mar 19, 2026. Filed Mar 19, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 19, 2026 · Filed Mar 19, 2026
Use the contents to explore the available documents and sections.
TNON$1.640.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (In thousands, except per share data)
(In thousands, except per share data)
| Years Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue | $3,944 | $3,277 |
| Cost of sales | 1,586 | 1,566 |
| Gross Profit | 2,358 | 1,711 |
| Operating Expenses | ||
| General and administrative | 6,975 | 7,765 |
| Sales and marketing | 6,026 | 5,109 |
| Research and development | 2,149 | 2,603 |
| Total Operating Expenses | 15,150 | 15,477 |
| Loss from Operations | (12,792) | (13,766) |
| Other Income (Expense) | ||
| Gain on investments | 236 | 183 |
| Interest expense | — | (34) |
| Other expense, net | — | (56) |
| Total Other Income (Expense), net | 236 | 93 |
| Net Loss | $(12,556) | $(13,673) |
| Net Loss Per Share of Common Stock | ||
| Basic and diluted | $(1.70) | $(11.26) |
| Weighted-Average Shares of Common Stock Outstanding | ||
| Basic and diluted | 7,384 | 1,214 |
| Statements of Comprehensive Loss: | ||
| Net loss | $(12,556) | $(13,673) |
| Foreign currency translation adjustment | — | 46 |
| Total Comprehensive Loss | $(12,556) | $(13,627) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.